Clinical Trials Evaluate New Treatment for Anal Cancer
Friday, January 20, 2017 - 11:01
in Health & Medicine
The addition of the drug cetuximab to a standard chemotherapy and radiation regimen reduced the incidence of disease persistence or recurrence in patients with anal cancer, but was also associated with significant adverse effects, according ... Read more